Anika Therapeutics, Inc. (ANIK)
14.27
-0.48
(-3.25%)
USD |
NASDAQ |
Mar 27, 16:00
14.27
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Total Assets (Quarterly) : 202.44M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 514.16M |
| Lantheus Holdings, Inc. | 2.227B |
| TELA Bio, Inc. | 82.03M |
| Plus Therapeutics, Inc. | 16.32M |
| BioStem Technologies, Inc. | 50.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.97M |
| Shareholders Equity (Quarterly) | 143.46M |
| Debt to Equity Ratio | 0.183 |
| Current Ratio | 4.718 |
| Net Debt Paydown Yield | 0.19% |